Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

3.985 +0.605 (+17.90%)

Delayed Quote Updated: 1:42 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bicycle Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Expert Ratings for Bicycle Therapeutics ↗

November 03, 2023

Via Benzinga

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day

November 02, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

October 30, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer

October 19, 2023

From Bicycle Therapeutics

Via Business Wire

Where Bicycle Therapeutics Stands With Analysts ↗

September 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023 ↗

September 12, 2023

Via Benzinga

Why Shares of Bicycle Therapeutics Were Rising on Monday ↗

September 11, 2023

The company said it is working with the FDA to structure a phase 2/3 trial for its bladder cancer therapy.

Via The Motley Fool

Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer

September 11, 2023

From Bicycle Therapeutics

Via Business Wire

Expert Ratings for Bicycle Therapeutics ↗

August 04, 2023

Via Benzinga

Bicycle Therapeutics's Return On Capital Employed Insights ↗

May 17, 2023

Via Benzinga

Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

September 05, 2023

From Bicycle Therapeutics

Via Business Wire

Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 03, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

July 18, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics PLC (NASDAQ: BCYC) Making Surprising Moves in Friday Session

May 12, 2023

Via Investor Brand Network

14 Analysts Have This to Say About Bicycle Therapeutics ↗

May 11, 2023

Via Benzinga

Recap: Bicycle Therapeutics Q1 Earnings ↗

May 04, 2023

Via Benzinga

Analyst Ratings for Bicycle Therapeutics ↗

April 18, 2023

Via Benzinga

Why Bicycle Therapeutics Stock Raced Ahead Today ↗

July 13, 2023

The company's latest attempt at capital raising seems to be having enviable success.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 13, 2023

Via Benzinga

Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On Thursday ↗

July 13, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) gained 18% to...

Via Benzinga

Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares

July 12, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares

July 12, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer

June 23, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics to Participate in the TD Cowen Radiopharmaceutical Innovation Summit

June 13, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference

May 31, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics and Orano Med Present Preclinical Bicycle® Radio-Conjugate Data at TIDES 2023

May 11, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology

May 10, 2023

From Bayer

Via Business Wire

Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 04, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets

May 04, 2023

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting

April 14, 2023

From Bicycle Therapeutics plc

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.